Hims & Hers Health, Inc. (HIMS) Dividend History

Company News

• Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights

  A securities class action lawsuit has been filed against Hims & Hers Health for allegedly selling illegitimate versions of Wegovy®, leading to Novo Nordisk terminating their partnership and causing a significant stock price decline.

  GlobeNewswire Inc.
• Oklo, NuScale, Hims Defy Trump Tariffs - And Power The Russell 2000 Toward New Highs

  Small-cap companies Oklo, NuScale, and Hims have demonstrated resilience against potential Trump tariffs, achieving significant year-to-date gains and contributing to the Russell 2000 index's upward momentum in clean energy and health tech sectors.

  Benzinga

  Featured Companies: IWM OKLO SMR
• Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash

  Hims & Hers experienced a stock decline after Novo Nordisk terminated their sales agreement, raising questions about the telehealth company's future recovery potential.

  The Motley Fool
• Hims & Hers Stock: Buy the Dip or Wait It Out?

  Hims & Hers Health (HIMS) is considering acquiring a European company, Zava, to expand its digital healthcare business. However, this move has raised concerns among investors due to increased regulation and geopolitical tensions between the US and EU, leading to a drop in the stock price. Analysts suggest waiting for a better entry point around $30-$32 per share to mitigate the short-term risks.

  Investing.com